Imaging of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography

被引:7
|
作者
Alazraki, N [1 ]
机构
[1] Emory Univ, Vet Affairs Med Ctr, Dept Radiol, Atlanta, GA 30322 USA
关键词
D O I
10.1016/S1091-255X(01)00058-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:136 / 138
页数:3
相关论文
共 50 条
  • [21] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer:: results of a multicentre study
    Grünwald, F
    Kälicke, T
    Feine, U
    Lietzenmayer, R
    Scheidhauer, K
    Dietlein, M
    Schober, O
    Lerch, H
    Brandt-Mainz, K
    Burchert, W
    Hiltermann, G
    Cremerius, U
    Biersack, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (12) : 1547 - 1552
  • [22] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
    Boerner, AR
    Weckesser, M
    Herzog, H
    Schmitz, T
    Audretsch, W
    Nitz, U
    Bender, HG
    Mueller-Gaertner, HW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (03) : 226 - 230
  • [23] CLINICAL SIGNIFICANCE OF FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR RECURRENT COLORECTAL CANCER
    Ishikawa, H.
    Watanabe, A.
    Ohyama, T.
    Mukogawa, T.
    Inoue, T.
    Kinoshita, S.
    Kawai, N.
    Nakagawa, K.
    Emoto, K.
    Ogawa, S.
    GUT, 2009, 58 : A86 - A86
  • [24] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study
    Frank Grünwald
    Thomas Kälicke
    Ulrich Feine
    Roland Lietzenmayer
    Klemens Scheidhauer
    Markus Dietlein
    Otmar Schober
    Hartmut Lerch
    Katja Brandt-Mainz
    Wolfgang Burchert
    Gerhard Hiltermann
    Uwe Cremerius
    Hans-Jürgen Biersack
    European Journal of Nuclear Medicine, 1999, 26 : 1547 - 1552
  • [25] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
    Boerner, A.R.
    Weckesser, M.
    Herzog, H.
    Schmitz, T.
    Audretsch, W.
    Nitz, U.
    Bender, H.G.
    Mueller-Gaertner, H.-W.
    European Journal of Nuclear Medicine and Molecular Imaging, 1999, 26 (03): : 226 - 230
  • [26] Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
    Grünwald, Frank
    Kälicke, Thomas
    Feine, Ulrich
    Lietzenmayer, Roland
    Scheidhauer, Klemens
    Dietlein, Markus
    Schober, Otmar
    Lerch, Hartmut
    Brandt-Mainz, Katja
    Burchert, Wolfgang
    Hiltermann, Gerhard
    Cremerius, Uwe
    Biersack, Hans-Jürgen
    European Journal of Nuclear Medicine and Molecular Imaging, 1999, 26 (12): : 1547 - 1552
  • [27] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer
    A. R. Boerner
    M. Weckesser
    H. Herzog
    T. Schmitz
    W. Audretsch
    U. Nitz
    H. G. Bender
    H.-W. Mueller-Gaertner
    European Journal of Nuclear Medicine, 1999, 26 : 226 - 230
  • [28] Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) - Usefulness and limitations in "clinical reality"
    Higashi, T
    Saga, T
    Nakamoto, Y
    Ishimori, T
    Fujimoto, K
    Doi, R
    Imamura, M
    Konishi, J
    ANNALS OF NUCLEAR MEDICINE, 2003, 17 (04) : 261 - 279
  • [29] Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) —Usefulness and limitations in “clinical reality”—
    Tatsuya Higashi
    Tsuneo Saga
    Yuji Nakamoto
    Takayoshi Ishimori
    Koji Fujimoto
    Ryuichiro Doi
    Masayuki Imamura
    Junji Konishi
    Annals of Nuclear Medicine, 2003, 17 : 261 - 279
  • [30] Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of T-lymphoblastic lymphoma patients
    Park, Jong Hoon
    Pahk, Kisoo
    Kim, Sungeun
    Lim, Sang Moo
    Cheon, Gi Jeong
    Park, Yeon Hee
    Lee, Seung-Sook
    Choe, Jae Gol
    ONCOLOGY LETTERS, 2016, 12 (02) : 1620 - 1622